The impact of cytomegalovirus infection ≥1 year after primary renal transplantation

被引:33
作者
Browne, Barry J. [3 ]
Young, Jo-Anne [2 ]
Dunn, Ty B. [1 ]
Matas, Arthur J. [1 ]
机构
[1] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
[3] Balboa Nephrology Med Grp Inc, Transplant Serv, San Diego, CA USA
关键词
cytomegalovirus; renal transplant; infection; post transplant; late; LATE-ONSET; KIDNEY-TRANSPLANTATION; ANTIVIRAL PROPHYLAXIS; LIVER-TRANSPLANTATION; DISEASE; RECIPIENTS; REACTIVATION; GANCICLOVIR; PREVENTION; ACYCLOVIR;
D O I
10.1111/j.1399-0012.2010.01208.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
We studied the impact of a first post-transplant cytomegalovirus (CMV) infection greater than one year after primary kidney transplantation. Risk factors for developing late CMV were acute rejection and donor-recipient CMV status. Of those developing late CMV, 35% were donor (D) positive, recipient (R) negative; however, 23% were D+R+, 22% D-R+, and 15% D-R-. Late CMV was associated with significantly decreased patient and graft survival.
引用
收藏
页码:572 / 577
页数:6
相关论文
共 20 条
  • [1] Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation
    Arthurs, Supha K.
    Eid, Albert J.
    Pedersen, Rachel A.
    Kremers, Walter K.
    Cosio, Fernando G.
    Patel, Robin
    Razonable, Raymund R.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (06) : 840 - 846
  • [2] Delayed-onset primary cytomegalovirus disease after liver transplantation
    Arthurs, Supha K.
    Eid, Albert J.
    Pedersen, Rachel A.
    Dierichising, Ross A.
    Kremers, Walter K.
    Patel, Robin
    Razonable, Raymund R.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (12) : 1703 - 1709
  • [3] A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ORAL ACYCLOVIR FOR THE PREVENTION OF CYTOMEGALO-VIRUS DISEASE IN RECIPIENTS OF RENAL-ALLOGRAFTS
    BALFOUR, HH
    CHACE, BA
    STAPLETON, JT
    SIMMONS, RL
    FRYD, DS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21) : 1381 - 1387
  • [4] BARNETT PS, 1984, S AFR MED J, V66, P635
  • [5] Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation
    Becker, BN
    Becker, YT
    Leverson, GE
    Simmons, WD
    Sollinger, HW
    Pirsch, JD
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (05) : 1088 - 1095
  • [6] CYTOMEGALOVIRUS DISEASE OF LATE-ONSET FOLLOWING RENAL-TRANSPLANTATION - A POTENTIALLY FATAL ENTITY
    BOEHLER, A
    SCHAFFNER, A
    SALOMON, F
    KEUSCH, G
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1994, 26 (04) : 369 - 373
  • [7] Late cytomegalovirus disease with atypical presentation in renal transplant patients: Case reports
    Boobes, Y
    Al Hakim, M
    Dastoor, H
    Bernieh, B
    Abdulkhalik, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (06) : 1841 - 1843
  • [8] Cytomegalovirus in transplantation -: challenging the status quo
    Fishman, Jay A.
    Emery, Vincent
    Freeman, Richard
    Pascual, Manuel
    Rostaing, Lionel
    Schlitt, Hans J.
    Sgarabotto, Dino
    Torre-Cisneros, Julian
    Uknis, Marc E.
    [J]. CLINICAL TRANSPLANTATION, 2007, 21 (02) : 149 - 158
  • [9] Late-onset cytomegalovirus reactivation in critically ill renal transplant patients
    Jochimsen, F
    Westhoff, T
    Engelmann, E
    Schafer, JH
    Offermann, G
    Zidek, W
    [J]. TRANSPLANTATION, 2003, 76 (02) : 430 - 432
  • [10] Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis
    Limaye, Ajit P.
    Bakthavatsalam, Ramasamy
    Kim, Hyung W.
    Randolph, Sara E.
    Halldorson, Jeffrey B.
    Healey, Patrick J.
    Kuhr, Christian S.
    Levy, Adam E.
    Perkins, James D.
    Reyes, Jorge D.
    Boeckh, Michael
    [J]. TRANSPLANTATION, 2006, 81 (12) : 1645 - 1652